The mineral dust-induced gene, mdig, regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1α signaling
- PMID: 33760153
- DOI: 10.3892/or.2021.8011
The mineral dust-induced gene, mdig, regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1α signaling
Abstract
Mineral dust‑induced gene (mdig) is a novel lung cancer‑related oncogene. The aim of this study was to explore the effects of mdig on angiogenesis and lymphangiogenesis by vascular endothelial growth factor (VEGF) in lung adenocarcinoma. mdig‑overexpressing A549, H1299 and 293T cells, mdig‑silenced A549, human umbilical vein endothelial cells (HUVECs) and human lymphatic endothelial cells (HLECs) were cultured under normoxic and hypoxic conditions. Protein expression levels of mdig, epidermal growth factor receptor (EGFR), phospho(p)‑EGFR Tyr1068, hypoxia‑inducible factor‑1α (HIF‑1α), VEGF‑A/C/D and VEGF‑R1/R2/R3 were assessed using western blotting. mRNA expression levels of mdig, EGFR and HIF‑1α were measured using RT‑qPCR. Tube formation and xenograft tumor experiments were performed to examine the mechanism of mdig in angiogenesis and lymphangiogenesis. Protein expression levels of EGFR, HIF‑1α and VEGF‑A/C/D were significantly upregulated in cells cultured under hypoxic conditions compared with those cultured under normoxic conditions, whereas the levels of mdig were decreased. Protein expression levels of EGFR, p‑EGFR and VEGF‑A/R1/R2 were significantly increased in the mdig‑overexpressing cells, whereas the levels of HIF‑1α and VEGF‑C/D/R3 were decreased compared with those in control cells, all of which were reversed in mdig‑silenced cells. Tumor volumes and density of angiogenesis in the mdig‑overexpressing group were significantly increased compared with those in the control group, whereas the density of lymphangiogenesis was decreased. No tumors formed in the mdig‑silenced group after 3 weeks of assessment in vivo. Protein expression levels of EGFR, p‑EGFR, VEGF‑A and angiogenesis density were significantly reduced in the mdig‑overexpressing cells treated with an EGFR inhibitor, whereas the levels of HIF‑1α, VEGF‑C/D and the lymphangiogenesis density were significantly increased in mdig‑overexpressing cells treated with a HIF‑1α agonist. All changes in protein expression were reversed in EGFR agonist and HIF‑1α inhibitor treated mdig‑silenced cells. In conclusion, mdig is an oxygen‑sensitive protein that promotes tumor growth and angiogenesis by activating the EGFR/p‑EGFR/VEGF‑A/VEGF‑R1/R2 pathway and inhibits lymphangiogenesis by blocking the HIF‑1α/VEGF‑C/D/VEGF‑R3 pathway.
Keywords: mineral dust‑induced gene; hypoxia; angiogenesis; lymphangiogenesis; lung adenocarcinoma; epidermal growth factor receptor; hypoxia‑inducible factor‑1α; vascular endothelial growth factor.
Similar articles
-
PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.Tissue Cell. 2022 Dec;79:101918. doi: 10.1016/j.tice.2022.101918. Epub 2022 Sep 6. Tissue Cell. 2022. PMID: 36148733
-
Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.Oncogene. 2018 Apr;37(15):1961-1975. doi: 10.1038/s41388-017-0089-8. Epub 2018 Jan 25. Oncogene. 2018. PMID: 29367761 Free PMC article.
-
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.IUBMB Life. 2018 Jan;70(1):81-91. doi: 10.1002/iub.1706. IUBMB Life. 2018. PMID: 29281186
-
New discoveries of mdig in the epigenetic regulation of cancers.Semin Cancer Biol. 2019 Aug;57:27-35. doi: 10.1016/j.semcancer.2019.06.013. Epub 2019 Jul 2. Semin Cancer Biol. 2019. PMID: 31276784 Free PMC article. Review.
-
New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.J Drug Target. 2021 Feb;29(2):155-167. doi: 10.1080/1061186X.2020.1815210. Epub 2020 Sep 3. J Drug Target. 2021. PMID: 32838575 Review.
Cited by
-
Advances in lymphatic metastasis of non-small cell lung cancer.Cell Commun Signal. 2024 Apr 2;22(1):201. doi: 10.1186/s12964-024-01574-1. Cell Commun Signal. 2024. PMID: 38566083 Free PMC article. Review.
-
Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease.J Clin Exp Hematop. 2024 Dec 25;64(4):297-306. doi: 10.3960/jslrt.24061. Epub 2024 Oct 28. J Clin Exp Hematop. 2024. PMID: 39462545 Free PMC article.
-
MDIG, a 2‑oxoglutarate‑dependent oxygenase, acts as an oncogene and predicts the prognosis of multiple types of cancer.Int J Oncol. 2022 Jul;61(1):82. doi: 10.3892/ijo.2022.5372. Epub 2022 May 18. Int J Oncol. 2022. PMID: 35583005 Free PMC article.
-
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.Target Oncol. 2023 Mar;18(2):195-207. doi: 10.1007/s11523-023-00946-w. Epub 2023 Feb 20. Target Oncol. 2023. PMID: 36805452 Free PMC article.
-
Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy.Clin Transl Oncol. 2025 May;27(5):1967-1979. doi: 10.1007/s12094-024-03727-7. Epub 2024 Sep 24. Clin Transl Oncol. 2025. PMID: 39317868 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous